Mechanism and implication of cephalosporin penetration into oropharyngeal mucosa
暂无分享,去创建一个
[1] F. Rasmussen. SALIVARY EXCRETION OF SULPHONAMIDES AND BARBITURATES BY COWS AND GOATS. , 2009, Acta pharmacologica et toxicologica.
[2] M. Jacobs,et al. Review of the spectrum and potency of orally administered cephalosporins and amoxicillin/clavulanate. , 2007, Diagnostic microbiology and infectious disease.
[3] M. Pichichero,et al. Meta-analysis of cephalosporins versus penicillin for treatment of group A streptococcal tonsillopharyngitis in adults. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[4] M. Pichichero,et al. Meta-analysis of cephalosporin versus penicillin treatment of group A streptococcal tonsillopharyngitis in children. , 2004, Pediatrics.
[5] D. Fish. Bronchoscopic sampling of drug concentrations: penetration to tissue is the issue. , 2003, American journal of respiratory and critical care medicine.
[6] W. Craig. Basic pharmacodynamics of antibacterials with clinical applications to the use of beta-lactams, glycopeptides, and linezolid. , 2003, Infectious disease clinics of North America.
[7] M. Jacobs,et al. Journal of Antimicrobial Chemotherapy , 2003 .
[8] F. Soriano,et al. Pharmacodynamic and kinetic basis for the selection of pneumococcal resistance in the upper respiratory tract. , 2002, The Journal of antimicrobial chemotherapy.
[9] I. Lamster,et al. The diagnostic applications of saliva--a review. , 2002, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.
[10] W. Craig. Does the dose matter? , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[11] R. Siegel. The significance of serum vs tissue levels of antibiotics in the treatment of penicillin-resistant Streptococcus pneumoniae and community-acquired pneumonia: are we looking in the wrong place? , 1999, Chest.
[12] B. Balkau,et al. Low dosage and long treatment duration of beta-lactam: risk factors for carriage of penicillin-resistant Streptococcus pneumoniae. , 1998, JAMA.
[13] R. Haeckel,et al. Application of saliva for drug monitoring. An in vivo model for transmembrane transport. , 1996, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.
[14] J. Williams,et al. Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella (Branhamella) catarrhalis isolated in the UK from sputa. , 1991, The Journal of antimicrobial chemotherapy.
[15] M. Powell,et al. In vitro susceptibility of Haemophilus influenzae to cefixime , 1987, Antimicrobial Agents and Chemotherapy.
[16] W. Risser,et al. Noncomparative, open label, multicenter trial of cefixime for treatment of bacterial pharyngitis, cystitis and pneumonia in pediatric patients. , 1987, The Pediatric infectious disease journal.
[17] R. Jones,et al. Cefixime: spectrum of antibacterial activity against 16,016 clinical isolates. , 1987, The Pediatric infectious disease journal.
[18] C. Chan,et al. Rapid high performance liquid chromatographic assay of cephalosporins in biological fluids. , 1986, The Journal of antimicrobial chemotherapy.
[19] L. Ayers,et al. In vitro evaluation of cefixime (FK027, FR17027, CL284635): spectrum against recent clinical isolates, comparative antimicrobial activity, beta-lactamase stability, and preliminary susceptibility testing criteria. , 1986, Diagnostic microbiology and infectious disease.
[20] L. Goodman,et al. THE PHARMACOLOGICAL BASIS OF THERAPEUTICS , 1966 .
[21] K. Kelly,et al. In vitro activity of cefixime (CL284635) and other antimicrobial agents against Haemophilus isolates from pediatric patients. , 1988, Chemotherapy.
[22] R. F. Vining,et al. Hormones in saliva. , 1986, Critical reviews in clinical laboratory sciences.
[23] Susan Budavari,et al. The Merck index : an encyclopedia of chemicals, drugs, and biologicals , 1983 .